Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + lidocaine hydrochloride + bupivacaine hydrochloride + triamcinolone acetonide
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Topical, Local Injection
01
Overview
This appears to be a **multi-ingredient topical or locally administered procedural combination** containing povidone-iodine, lidocaine hydrochloride, bupivacaine hydrochloride, and triamcinolone acetonide. Pharmacologically, the mixture combines an antiseptic/disinfectant component with two amide local anesthetics and a corticosteroid: povidone-iodine releases free iodine with broad microbicidal activity; lidocaine and bupivacaine block voltage-gated sodium channels to produce local anesthesia and analgesia, with lidocaine providing relatively rapid onset and bupivacaine longer duration; triamcinolone acetonide is a glucocorticoid receptor agonist used to suppress local inflammation. Based on the name alone, the intended use is most consistent with local or regional procedural analgesia/anesthesia with antiseptic preparation and anti-inflammatory effect, but the exact branded product, sponsor, dosage form, and regulated indication are not identifiable from the provided evidence. The cited context mainly supports the presence and anesthetic role of bupivacaine rather than verification of this exact four-drug fixed combination.
- Other names
- povidone-iodine + lidocaine hydrochloride + bupivacaine hydrochloride + triamcinolone acetonide
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on povidone-iodine + lidocaine hydrochloride + bupivacaine hydrochloride + triamcinolone acetonide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + lidocaine hydrochloride + bupivacaine hydrochloride + triamcinolone acetonide.